Child vaccine trials paused
The trial of the Oxford-AstraZeneca Covid vaccine in children has been paused while a possible link with blood clots in adults is investigated. Given that the phase 3 adult vaccine trials to establish long-term safety data are on-going and are not due to conclude until late 2022/early 2023, the question remains why were trials in children ever started? The risks to children from COVID-19 remain extremely low and any suggestion that children should be vaccinated to protect adults is ethically highly questionable.
HART’s position remains that it is unnecessary, unethical and should be strongly discouraged until long-term safety data in adults are complete. HART would also remind regulators, the media and politicians that these are experimental vaccines, without full regulatory approval but issued under emergency waivers. It is vital that data is collected and rigorous scrutiny of vaccine effects is completed and letters such as this one in The BMJ must surely be followed up as a matter of urgency…
Read More